These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 4026990)

  • 1. Nonenzymatic glycation of immunoglobulins leads to an impairment of immunoreactivity.
    Dolhofer R; Siess EA; Wieland OH
    Biol Chem Hoppe Seyler; 1985 Apr; 366(4):361-6. PubMed ID: 4026990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impairment by glycation of immunoglobulin G Fc fragment function.
    Dolhofer-Bliesener R; Gerbitz KD
    Scand J Clin Lab Invest; 1990 Nov; 50(7):739-46. PubMed ID: 2149885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonenzymatic glycosylation of immunoglobulin G impairs complement fixation.
    Hennessey PJ; Black CT; Andrassy RJ
    JPEN J Parenter Enteral Nutr; 1991; 15(1):60-4. PubMed ID: 2008035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro glycation of human immunoglobulin G.
    Vrdoljak A; Trescec A; Benko B; Hecimovic D; Simic M
    Clin Chim Acta; 2004 Jul; 345(1-2):105-11. PubMed ID: 15193984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impaired immunoglobulin G Fc fragment function in diabetics is caused by a mechanism different from glycation.
    Dolhofer-Bliesener R; Lechner B; Gerbitz KD
    Eur J Clin Chem Clin Biochem; 1994 May; 32(5):329-36. PubMed ID: 8086514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonenzymatic glycation of human platelet membrane proteins in vitro and in vivo.
    Sampietro T; Lenzi S; Cecchetti P; Giampietro O; Cruschelli L; Navalesi R
    Clin Chem; 1986 Jul; 32(7):1328-31. PubMed ID: 3719941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of nonenzymatic glycation on the structure of immunoglobulin G.
    Dolhofer-Bliesener R; Gerbitz KD
    Biol Chem Hoppe Seyler; 1990 Aug; 371(8):693-7. PubMed ID: 2206457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of antibody and complement in the immune clearance and destruction of erythrocytes. II. Molecular nature of IgG and IgM complement-fixing sites and effects of their interaction with serum.
    Schreiber AD; Frank MM
    J Clin Invest; 1972 Mar; 51(3):583-9. PubMed ID: 4622104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonenzymic glycation of human immunoglobulins does not impair their immunoreactivity.
    Morin LG; Austin GE; Rodey GE; Johnson JE
    Clin Chem; 1989 Jun; 35(6):1039-42. PubMed ID: 2543516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between serum anti-varicella zoster virus antibody titer and time from onset of herpes zoster.
    Ihara H; Miyachi M; Imafuku S
    J Dermatol; 2018 Feb; 45(2):189-193. PubMed ID: 29239011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonenzymatic glycation of immunoglobulins does not impair antigen-antibody binding.
    Morin LG; Austin GE; Burkhalter A
    Clin Chem; 1987 May; 33(5):692-4. PubMed ID: 3568354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preferential recognition of Amadori-rich lysine residues by serum antibodies in diabetes mellitus: role of protein glycation in the disease process.
    Ansari NA; Moinuddin ; Alam K; Ali A
    Hum Immunol; 2009 Jun; 70(6):417-24. PubMed ID: 19332092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-enzymatic glucosylation induced neo-epitopes on human serum albumin: A concentration based study.
    Neelofar K; Arif Z; Ahmad J; Alam K
    PLoS One; 2017; 12(2):e0172074. PubMed ID: 28192530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rates and impact of human antibody glycation in vivo.
    Goetze AM; Liu YD; Arroll T; Chu L; Flynn GC
    Glycobiology; 2012 Feb; 22(2):221-34. PubMed ID: 21930650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro Glycation of Human IgG and Its Effect on Interaction with Anti-IgG.
    Goodarzi MT; Ghahraman S; Mirmomeni MH
    Iran J Allergy Asthma Immunol; 2004 Dec; 3(4):181-7. PubMed ID: 17301412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined use of complement and anti-immunoglobulin in an enhanced neutralization assay for antibodies to varicella-zoster virus.
    Krah DL; Provost PJ; Ellis RW
    J Virol Methods; 1995 Jun; 53(2-3):176-87. PubMed ID: 7673386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complement-fixing islet-cell antibodies: a separate species?
    Riley WJ; Neufeld M; Maclaren NK
    Lancet; 1980 May; 1(8178):1133. PubMed ID: 6103458
    [No Abstract]   [Full Text] [Related]  

  • 18. [Complement-binding activity of myeloma and normal immune complexes].
    Lavrent'ev VV; Konstantinova NA; Tumanova IA
    Biull Eksp Biol Med; 1986 Feb; 101(2):183-5. PubMed ID: 3947736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Significance of aromatic amino acid residues for certain functions of immunoglobulins].
    Bezvershenko IA; Bykova LM; Demchenko AP
    Ukr Biokhim Zh (1978); 1981; 53(5):3-8. PubMed ID: 7292619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complement fixation by a two-component antibody system: immunoglobulin G and immunoglobulin M anti-globulin (rheumatoid factor). Parodoxical effect related to immunoglobulin G concentration.
    Schmid FR; Roitt IM; Rocha MJ
    J Exp Med; 1970 Oct; 132(4):673-93. PubMed ID: 5508376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.